Search alternatives:
reported decrease » reported disease (Expand Search), reported depressive (Expand Search), reported case (Expand Search)
studies reported » studies revealed (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
market decrease » marked decrease (Expand Search), marked increase (Expand Search), larger decrease (Expand Search)
reported decrease » reported disease (Expand Search), reported depressive (Expand Search), reported case (Expand Search)
studies reported » studies revealed (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
market decrease » marked decrease (Expand Search), marked increase (Expand Search), larger decrease (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Post-marketing safety of panitumumab: a real-world pharmacovigilance study
Published 2024“…<p>Panitumumab has been extensively applied in antitumor therapy, and the regulation of its adverse drug reactions (ADRs) has become extremely important. This study utilized the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) database to extract real-world panitumumab ADR signals and provide relevant information for drug safety.…”
-
8
-
9
-
10
-
11
Inotodiol decreases clone formation in HCC cells.
Published 2025“…Therefore, finding novel low-toxicity and high-efficiency anti-hepatocellular carcinoma drugs and exploring their mechanisms of action have become the current problems to be solved in the treatment of HCC. Several studies have reported anticancer effects of inotodiol. …”
-
12
-
13
-
14
-
15
-
16
-
17
-
18
Decreased expression of TCA cycle and ETC enzymes in kidneys from rats administered Tl.
Published 2024Subjects: -
19
-
20